Detail akcie Alliance Pharma online

Business Summary: Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Alliance Pharma plc revenues increased 8% to L180.7M. Net loss increased 56% to L33.1M. Revenues reflect Consumer Healthcare segment increase of 11% to L134.3M, Asia Pacific and china segment increase of 22% to L72.4M, Europe & Middle East & Africa (EMEA) (Region) segment increase of less than 1% to L79.2M.